Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
1996 · The Journal of Immunology · 449 citations
https://doi.org/10.4049/jimmunol.157.5.1823
J
Jack R. Bennink
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
245
Papers
25.5K
Citations
87
h-index
189
i10-index
Jack R. Bennink is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 87, co-authored 209 publications.
Papers by this author
worksCell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes
1992 · Advances in immunology · 365 citations
https://doi.org/10.1016/s0065-2776(08)60875-5
Antigen processing in vivo and the elicitation of primary CTL responses.
1995 · The Journal of Immunology · 221 citations
https://doi.org/10.4049/jimmunol.154.9.4414
Cutting Edge: Adenovirus E19 Has Two Mechanisms for Affecting Class I MHC Expression
1999 · The Journal of Immunology · 212 citations
https://doi.org/10.4049/jimmunol.162.9.5049
MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL
1997 · The Journal of Immunology · 202 citations
https://doi.org/10.4049/jimmunol.158.4.1507
Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response
1991 · The Journal of Immunology · 115 citations
https://doi.org/10.4049/jimmunol.147.4.1453
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat